Centessa Pharmaceuticals PLC ADR (CNTA) Insider Trading
- $9,101,824.86
- $19,339,012.56
- June 25, 2025
- Saurabh Saha
Trader Name | Date | Title | Amount | Price | Type | Total Value |
---|---|---|---|---|---|---|
June 25, 2025 | Insider | 10,000 | $13.86 | Sell | $138,600.00 | |
June 24, 2025 | Insider | 15,000 | $14.00 | Sell | $210,000.00 | |
June 24, 2025 | General Counsel | 12,000 | $14.02 | Sell | $168,240.00 | |
June 20, 2025 | CEO | 55,000 | $12.63 | Sell | $694,650.00 | |
May 27, 2025 | Insider | 10,000 | $12.82 | Sell | $128,200.00 | |
May 20, 2025 | CEO | 55,000 | $12.71 | Sell | $699,050.00 | |
May 16, 2025 | Director | 417,646 | $12.73 | Buy | $5,316,633.58 | |
May 15, 2025 | Director | 44,939 | $12.24 | Buy | $550,053.36 | |
May 1, 2025 | General Counsel | 311 | $14.00 | Sell | $4,354.00 | |
April 28, 2025 | General Counsel | 2,080 | $14.01 | Sell | $29,140.80 | |
April 25, 2025 | General Counsel | 3,609 | $14.00 | Sell | $50,526.00 | |
April 25, 2025 | Insider | 11,742 | $13.61 | Sell | $159,808.62 | |
April 21, 2025 | CEO | 14,656 | $12.29 | Sell | $180,122.24 | |
March 25, 2025 | Insider | 10,000 | $16.34 | Sell | $163,400.00 | |
March 20, 2025 | CEO | 55,000 | $16.69 | Sell | $917,950.00 | |
March 17, 2025 | General Counsel | 6,000 | $16.45 | Sell | $98,700.00 | |
March 17, 2025 | Insider | 7,000 | $17.17 | Sell | $120,190.00 | |
Feb. 20, 2025 | CEO | 55,000 | $15.93 | Sell | $876,150.00 | |
Feb. 18, 2025 | General Counsel | 6,000 | $16.18 | Sell | $97,080.00 | |
Feb. 10, 2025 | Insider | 429 | $18.99 | Sell | $8,146.71 | |
Feb. 7, 2025 | Insider | 30,526 | $19.03 | Sell | $580,909.78 | |
Feb. 3, 2025 | Insider | 6,471 | $16.86 | Sell | $109,101.06 | |
Feb. 3, 2025 | CTO | 11,000 | $16.86 | Sell | $185,460.00 | |
Jan. 27, 2025 | Insider | 11,742 | $16.47 | Sell | $193,390.74 | |
Jan. 21, 2025 | CEO | 55,000 | $15.77 | Sell | $867,350.00 | |
Jan. 15, 2025 | General Counsel | 6,000 | $15.29 | Sell | $91,740.00 | |
Dec. 26, 2024 | Insider | 10,000 | $17.04 | Sell | $170,400.00 | |
Dec. 20, 2024 | CEO | 55,000 | $17.44 | Sell | $959,200.00 | |
Dec. 17, 2024 | Insider | 10,624 | $17.32 | Sell | $184,007.68 | |
Dec. 17, 2024 | CTO | 17,813 | $18.00 | Sell | $320,634.00 | |
Dec. 16, 2024 | General Counsel | 77,705 | $16.39 | Sell | $1,273,584.95 | |
Dec. 13, 2024 | Insider | 5,876 | $17.01 | Sell | $99,950.76 | |
Dec. 6, 2024 | CEO | 87,496 | $18.46 | Sell | $1,615,176.16 | |
Nov. 25, 2024 | Insider | 10,000 | $17.66 | Sell | $176,600.00 | |
Nov. 25, 2024 | CEO | 299 | $18.23 | Sell | $5,450.77 | |
Nov. 22, 2024 | CEO | 1,671 | $18.24 | Sell | $30,479.04 | |
Nov. 20, 2024 | CEO | 55,000 | $16.89 | Sell | $928,950.00 | |
Oct. 25, 2024 | Insider | 11,742 | $15.38 | Sell | $180,591.96 | |
Oct. 23, 2024 | CEO | 2,592 | $15.32 | Sell | $39,709.44 | |
Oct. 21, 2024 | CEO | 22,205 | $15.80 | Sell | $350,839.00 | |
Sept. 25, 2024 | Insider | 16,619 | $15.69 | Sell | $260,752.11 | |
Sept. 20, 2024 | CEO | 55,000 | $16.53 | Sell | $909,150.00 | |
Sept. 10, 2024 | CEO | 175,000 | $16.52 | Sell | $2,891,000.00 | |
Sept. 9, 2024 | Insider | 25,000 | $15.00 | Sell | $375,000.00 | |
Aug. 22, 2024 | CEO | 506 | $12.23 | Sell | $6,188.38 | |
Aug. 22, 2024 | Insider | 12,198 | $12.17 | Sell | $148,449.66 | |
Aug. 20, 2024 | CEO | 4,169 | $12.32 | Sell | $51,362.08 | |
March 25, 2024 | Insider | 51,160 | $11.88 | Sell | $607,780.80 | |
Feb. 1, 2024 | SVP | 4,267 | $8.10 | Sell | $34,562.70 | |
Sept. 20, 2023 | SVP | 37,484 | $6.29 | Sell | $235,774.36 |
Insiders are both buying and selling Centessa Pharmaceuticals PLC ADR stock.
The insider traders at Centessa Pharmaceuticals PLC ADR are: Saurabh Saha, Gregory M Weinhoff, Antoine Yver, Iqbal J Hussain, Karen M Anderson, Tia L Bush, Rubertis Francesco De, David M Chao, Harris Rotman, Medicxi Ventures Management (J, Arjun Goyal, Thomas Templeman, Mario Alberto Accardi, Aaron Kantoff, and David J Grainger
The most active insider trader at Centessa Pharmaceuticals PLC ADR is Saurabh Saha with 20 trades.
Saurabh Saha has sold the most Centessa Pharmaceuticals PLC ADR stock with a total value of $12,717,427.11.
Arjun Goyal has bought the most Centessa Pharmaceuticals PLC ADR stock with a total value of $11,183,320.52.
The most recent insider trade for Centessa Pharmaceuticals PLC ADR was on June 25, 2025.
The single biggest insider buy for Centessa Pharmaceuticals PLC ADR was from Arjun Goyal with a total value of $5,316,633.58 on May 16, 2025.
The single biggest insider sell for Centessa Pharmaceuticals PLC ADR was from Saurabh Saha with a total value of $2,891,000.00 on Sept. 10, 2024.